Historique de carrière de Stacey L. Jurchison
Anciens postes connus de Stacey L. Jurchison
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | 01/06/2019 | - |
| Public Communications Contact | 01/06/2019 | 01/04/2022 | |
| ALTIMMUNE, INC. | Investor Relations Contact | - | - |
| REXAHN PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| APTEVO THERAPEUTICS INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Investor Relations Contact | - | - |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Investor Relations Contact | 5 |
| Public Communications Contact | 3 |
Sectorielle
| Health Technology | 6 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Entreprise privées | 2 |
|---|---|
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
- Bourse
- Insiders
- Stacey L. Jurchison
- Expérience
